BHCM
MEDP icon

Brevan Howard Capital Management’s Medpace MEDP Stock Holding History

Brevan Howard Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,946
Closed -$996K – 2344
2025
Q4 		$1.09M Sell
1,946
-5,295
-73% -$3.01M 0.01% 725
2025
Q3 		$3.72M Sell
7,241
-5,070
-41% -$2.21M 0.02% 319
2025
Q2 		$3.86M Buy
12,311
+8,241
+202% +$2.47M 0.02% 465
2025
Q1 		$1.24M Buy
+4,070
New +$1.37M 0.01% 427
2024
Q4 		– Sell
-861
Closed -$287K – 1282
2024
Q3 		$287K Buy
+861
New +$327K ﹤0.01% 874
2024
Q1 		– Sell
-814
Closed -$250K – 1215
2023
Q4 		$250K Buy
+814
New +$220K ﹤0.01% 797

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Brevan Howard Capital Management's MEDP Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Medpace (MEDP) in Q1 2026, closing a stake of 1,946 shares — an estimated $996K sold.

Brevan Howard Capital Management first reported a position in MEDP in Q4 2023 and held it in 6 quarters. The position peaked at $3.86M in Q2 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 1,946 Medpace shares in Q1 2026, an estimated $996K.
  • Brevan Howard Capital Management first reported a position in Medpace in Q4 2023 and held it in 6 quarters.
  • Brevan Howard Capital Management's Medpace position peaked at $3.86M in Q2 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.